BiotechTube

Pitavastatin + Pravastatin

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Dyslipidemia

Conditions

Dyslipidemia

Trial Timeline

Dec 1, 2010 → Mar 1, 2013

NCT ID
NCT01301066

About Pitavastatin + Pravastatin

Pitavastatin + Pravastatin is a approved stage product being developed by Eli Lilly for Dyslipidemia. The current trial status is completed. This product is registered under clinical trial identifier NCT01301066. Target conditions include Dyslipidemia.

What happened to similar drugs?

14 of 20 similar drugs in Dyslipidemia were approved

Approved (14) Terminated (3) Active (4)
✅Rosuampin 10/5mg + Rosuampin 20/5mg + Amlodipine/Atorvastatin 5/20mgYuhanApproved
✅rosuvastatin + placebo + rosuvastatin + atorvastatinAstraZenecaApproved
✅FluvastatinNovartisApproved
✅Fluvastatin extended release, fenofibrate + Fixed combination simvastatin/ezetimibeNovartisApproved
✅FluvastatinNovartisApproved
✅Atorvastatin + AtorvastatinPfizerApproved
✅AtorvastatinPfizerApproved

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01301066ApprovedCompleted

Competing Products

20 competing products in Dyslipidemia

See all competitors
ProductCompanyStageHype Score
LY3202328 + Placebo + Atorvastatin + SimvastatinEli LillyPhase 1
29
Rosuampin 10/5mg + Rosuampin 20/5mg + Amlodipine/Atorvastatin 5/20mgYuhanApproved
43
YH14755 + Metformin + RosuvastatinYuhanPhase 3
40
YHR1705 + YHR1706 + YHR1705+YHR1706YuhanPhase 1
29
Moderate-intensity statin monotherapy + Ezetimibe or ezetimibe-statin combination therapyYuhanPre-clinical
33
Crestor 20mg(Rosuvastatin 20mg), Micardis 80mg(Telmisartan 80mg) , FDCYuhanPhase 1
29
MevalotinDaiichi SankyoPre-clinical
26
PravastatinDaiichi SankyoPre-clinical
26
LY3475766 - IV + LY3475766 - SC + Placebo - IV + Placebo - SCEli LillyPhase 1
29
LY3885125 + PlaceboEli LillyPhase 1
21
LY3561774 + PlaceboEli LillyPhase 1
29
LY2484595 + Atorvastatin + Simvastatin + Rosuvastatin + Placebo for LY2484595 + Placebo for StatinsEli LillyPhase 2
35
LY3561774 + PlaceboEli LillyPhase 2
35
LY2484595 + Placebo + AtorvastatinEli LillyPhase 2
35
EvacetrapibEli LillyPhase 1
29
PPAR alpha + placeboEli LillyPhase 2
35
AZD0780 + Ezetimibe + Rosuvastatin + Bempedoic Acid + PlaceboAstraZenecaPhase 1
29
ABT-335 + RosuvastatinAstraZenecaPhase 1
29
AZD6615 + PlaceboAstraZenecaPhase 1
21
AZD0780 + AZD0780 + AZD0780 + Placebo + Placebo + Placebo + RosuvastatinAstraZenecaPhase 1
29